The Morning Brief cover image

Biocon's Biosimilar Blues

The Morning Brief

00:00

Biocon - The Challenges They Will Face

Biosimilars is extremely complicated in terms of the manufacturing processes. Biocon will have to watch and take every step very carefully, so far as it'sa facturing and supply chain is concerned. It'll be interesting to see whether this incident will be written of as a nee jerk reaction or one that was justifyit. And finally, we got vicars to draw up a list of challenges that biocon could face, as well as what he thinks they should actively look at going forward.

Play episode from 20:31
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app